{
    "clinical_study": {
        "@rank": "77465", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I.  Assess the biosynthesis of cholesterol and cholestanol, and measure the\n      turnover of individual sterols and bile acids in patients with cerebrotendinous\n      xanthomatosis before and after a cholesterol- and cholestanol-free diet.\n\n      II.  Assess the biosynthesis of cholesterol and cholestanol, and measure the turnover of\n      individual sterols and bile acids in these patients before and after lovastatin and\n      chenodeoxycholic acid."
        }, 
        "brief_title": "Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis", 
        "condition": "Cerebrotendinous Xanthomatosis", 
        "condition_browse": {
            "mesh_term": [
                "Xanthomatosis", 
                "Xanthomatosis, Cerebrotendinous"
            ]
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE: Following a 2-week baseline assessment, patients participate in a feeding\n      study for up to 3 weeks.  The diet is free of cholesterol and cholestanol.\n\n      For the next 4 weeks, patients return to their typical diet and are medicated with daily\n      lovastatin and chenodeoxycholic acid.\n\n      The feeding study is repeated for an additional 3 weeks, with the patient taking either\n      lovastatin or chenodeoxycholic acid."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA: Cerebrotendinous xanthomatosis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "5", 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004346", 
            "org_study_id": "NCRR-M01RR00334-0067", 
            "secondary_id": "OHSU-4008"
        }, 
        "intervention": [
            {
                "intervention_name": "chenodeoxycholic acid", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "lovastatin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Chenodeoxycholic Acid", 
                "Lovastatin"
            ]
        }, 
        "keyword": [
            "cerebrotendinous xanthomatosis", 
            "inborn errors of metabolism", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "contact": {
                "email": "connors@ohsu.edu", 
                "last_name": "Sonja Connor", 
                "phone": "503-494-7775"
            }, 
            "facility": {
                "address": {
                    "city": "Portland", 
                    "country": "United States", 
                    "state": "Oregon", 
                    "zip": "97239-3098"
                }, 
                "name": "Oregon Health and Science University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Effects of Diet and Medication in Patients With Cerebrotendinous Xanthomatosis (CTX)", 
        "overall_official": {
            "affiliation": "Oregon Health and Science University", 
            "last_name": "William Connor", 
            "role": "Study Chair"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 2", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004346"
        }, 
        "source": "National Center for Research Resources (NCRR)", 
        "sponsors": {
            "collaborator": {
                "agency": "Oregon Health and Science University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "January 1996", 
        "study_design": "Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2003"
    }, 
    "geocoordinates": {
        "Oregon Health and Science University": "45.523 -122.676"
    }
}